At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
ACUVUE® OASYS with Transitions™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of A Marketed Silicone Hydrogel Spherical Lens Used for Monovision Correction of Presbyopia
In Brief
A clinical study evaluating ACUVUE® OASYS with Transitions™ for Visual Acuity. Completed, enrolled 91 participants across 5 sites.
Detailed Summary
This is a single-masked, dispensing clinical trial. A total of approximately 48 myopic and 32 hyperopic eligible subjects will be targeted to complete the study. Subjects will be fit in the study lens, optimized if required and worn for approximately 2 weeks. Subjects will then have a washout period of approximately 1 week and be refit in the lenses and be dispensed for an additional 2 weeks of wear.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedAug 2019
Primary CompletionMar 2020
TodayJul 2026
First PostedAug 29, 2019
Enrollment StartAug 7, 2019
Primary CompletionMar 20, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.8 years ago
Interventions
ACUVUE® OASYS with Transitions™device
JJVC Marketed Contact Lens